Astellas Pharma Inc. (OTCMKTS:ALPMY) Sees Significant Growth in Short Interest
Astellas Pharma Inc. (OTCMKTS:ALPMY – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 138,700 shares, a growth of 87.2% from the May 15th total of 74,100 shares. Based on an average daily volume of 647,900 shares, […]
More Stories
Primecap Management Co. CA Increases Position in Glaukos Co. (NYSE:GKOS)
Primecap Management Co. CA boosted its stake in shares of Glaukos Co. (NYSE:GKOS – Free Report) by 2.0% during the...
Moors & Cabot Inc. Has $1.51 Million Stock Holdings in Kosmos Energy Ltd. (NYSE:KOS)
Moors & Cabot Inc. increased its stake in shares of Kosmos Energy Ltd. (NYSE:KOS – Free Report) by 3.5% during...
DexCom, Inc. (NASDAQ:DXCM) Holdings Lifted by Cornerstone Advisors LLC
Cornerstone Advisors LLC lifted its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 25.0% in the 3rd...
Cypress Capital Group Sells 793 Shares of iShares Core MSCI EAFE ETF (BATS:IEFA)
Cypress Capital Group lessened its stake in shares of iShares Core MSCI EAFE ETF (BATS:IEFA – Free Report) by 7.5%...
Cypress Capital Group Has $437,000 Position in Entergy Corporation (NYSE:ETR)
Cypress Capital Group cut its stake in Entergy Corporation (NYSE:ETR – Free Report) by 4.4% in the 3rd quarter, Holdings...
Cypress Capital Group Buys Shares of 2,650 AstraZeneca PLC (NASDAQ:AZN)
Cypress Capital Group acquired a new position in AstraZeneca PLC (NASDAQ:AZN – Free Report) during the third quarter, Holdings Channel...